Edity (Seed+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$19,800,000
Company Info
Founders
Michal Mashiach
Market
Healthcare & Wellness
Coinvestors
Tal Ventures,Reinforced Ventures,NFX
Company Description

A biotech company building a platform that harnesses the immune system to deliver therapeutic proteins direct to the cytoplasm of target cells to reprogram cells and tissue back to health. EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells.